“Agate” is a family of structurally related ingredients with applications in personal care. The identity of the Agate family is not yet public.

In 2013, Evolva exclusively partnered certain ingredients in the Agate family with Ajinomoto (Tokyo, Japan). The partnership involves pathway creation and strain improvement, with Ajinomoto paying Evolva research fees. In early 2015 Ajinomoto paid Evolva a milestone payment. The project has now progressed to the point of providing Ajinomoto a go-to market solution.

If Ajinomoto commercialises its Agate ingredients, Evolva is due royalties. Evolva also expects to earn revenues from commercialising those Agate family ingredients that it retains rights to.


  • Making alliances work

    Evolva believes that good collaborations require good communication, good science and engineering, and of course good results.

    Harvard Bus. Review
More articles
  • Topped our upper estimate! Evolva raises CHF 86M ($86M). Cash position now > CHF 100M ($100M).

Sign up to receive our
Press Releases!

Sign up